In this letter Gorman discussed items on a proposed budget for the glaucoma organization's first year, which was to be funded by Fiskett's company, Merck, Sharp, & Dohme. His comments about the duties of an associate director, expenses for consultants, and the costs of newsletters reveal much about the day-to-day operations of such an organization.
Copyright:
The National Library of Medicine believes this item to be in the public domain. (More information)
